<bill session="117" type="h" number="2934" updated="2023-01-11T13:48:31Z">
  <state datetime="2021-04-30">REFERRED</state>
  <status>
    <introduced datetime="2021-04-30"/>
  </status>
  <introduced datetime="2021-04-30"/>
  <titles>
    <title type="display">RAISE Act</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to remove from the list of drugs excluded from coverage under the Medicare prescription drug program prescription oral vitamins and mineral products indicated for the treatment of iron deficiency anemia in individuals with chronic kidney disease.</title>
    <title type="short" as="introduced">RAISE Act</title>
    <title type="short" as="introduced">Renal Anemia Innovation Support and Expansion Act</title>
  </titles>
  <sponsor bioguide_id="O000171"/>
  <cosponsors>
    <cosponsor bioguide_id="B001275" joined="2021-04-30"/>
    <cosponsor bioguide_id="B001251" joined="2021-04-30"/>
    <cosponsor bioguide_id="C001120" joined="2021-07-22"/>
    <cosponsor bioguide_id="L000576" joined="2021-07-29"/>
    <cosponsor bioguide_id="M001190" joined="2021-04-30"/>
    <cosponsor bioguide_id="S001172" joined="2021-07-27"/>
  </cosponsors>
  <actions>
    <action datetime="2021-04-30">
      <text>Introduced in House</text>
    </action>
    <action datetime="2021-04-30" state="REFERRED">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-04-30">
      <text>Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2021-04-30">
      <text>Referred to the Subcommittee on Social Security.</text>
    </action>
    <action datetime="2021-04-30">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2021-05-03">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee code="HSIF" name="House Energy and Commerce" subcommittee="" activity="Referral"/>
    <committee code="HSIF14" name="House Energy and Commerce" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM" name="House Ways and Means" subcommittee="" activity="Referral"/>
    <committee code="HSWM02" name="House Ways and Means" subcommittee="Health" activity="Referral"/>
    <committee code="HSWM01" name="House Ways and Means" subcommittee="Social Security" activity="Referral"/>
  </committees>
  <relatedbills/>
  <subjects>
    <term name="Health"/>
    <term name="Blood and blood diseases"/>
    <term name="Digestive and metabolic diseases"/>
    <term name="Health care coverage and access"/>
    <term name="Medicare"/>
    <term name="Prescription drugs"/>
  </subjects>
  <amendments/>
  <summary date="2021-06-23T13:33:26Z" status="Introduced in House">Renal Anemia Innovation Support and Expansion Act or the RAISE Act

This bill allows coverage of prescription vitamin and mineral products under the Medicare prescription drug benefit if the products are administered orally and are used to treat iron deficiency anemia in individuals who have chronic kidney disease.</summary>
</bill>
